Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

NCT07042919 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma
Cirrhosis
Stage III Hepatocellular Carcinoma AJCC v8
Stage IV Hepatocellular Carcinoma AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography Test
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Multigated Acquisition Scan
DRUG: Zanzalintinib

Sponsor

Northwestern University

Collaborators

[object Object]